McWherter Charles's Form 4 filing
CymaBay Therapeutics, Inc. (CBAY) · filed Jan 22, 2024
- Accession no.
- 0001062993-24-001164
- Filed
- Jan 22, 2024
- Trade date
- Jan 19, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Checked
This filing lists 10 non-derivative transactions and 5 derivative transactions. Open-market sales total $435.7K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| McWherter CharlesCIK 0001588862 | Officer (President of R&D) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 19, 2024 | Common Stock | MOption exerciseAcquired | +2,250 | $1.06 | +$2,385 | 17,250 | Direct | |
| Jan 19, 2024 | Common Stock | SSaleDisposed | −2,250 | $23.67 | −$53,257.5 | 15,000 | Direct | |
| Jan 19, 2024 | Common Stock | MOption exerciseAcquired | +2,778 | $1.72 | +$4,778.16 | 17,778 | Direct | |
| Jan 19, 2024 | Common Stock | SSaleDisposed | −2,778 | $23.66 | −$65,727.48 | 15,000 | Direct | |
| Jan 19, 2024 | Common Stock | MOption exerciseAcquired | +1,916 | $1.82 | +$3,487.12 | 16,916 | Direct | |
| Jan 19, 2024 | Common Stock | SSaleDisposed | −1,916 | $23.66 | −$45,332.56 | 15,000 | Direct | |
| Jan 19, 2024 | Common Stock | MOption exerciseAcquired | +8,334 | $10.00 | +$83,340 | 23,334 | Direct | |
| Jan 19, 2024 | Common Stock | SSaleDisposed | −8,334 | $23.68 | −$197,349.12 | 15,000 | Direct | |
| Jan 19, 2024 | Common Stock | MOption exerciseAcquired | +3,125 | $11.69 | +$36,531.25 | 18,125 | Direct | |
| Jan 19, 2024 | Common Stock | SSaleDisposed | −3,125 | $23.68 | −$74,000 | 15,000 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 19, 2024 | Common Stock | MOption exerciseDisposed | −2,250 | $0.00 | $0 | 51,750 | Direct | |
| Jan 19, 2024 | Common Stock | MOption exerciseDisposed | −2,778 | $0.00 | $0 | 97,222 | Direct | |
| Jan 19, 2024 | Common Stock | MOption exerciseDisposed | −1,916 | $0.00 | $0 | 44,084 | Direct | |
| Jan 19, 2024 | Common Stock | MOption exerciseDisposed | −8,334 | $0.00 | $0 | 91,666 | Direct | |
| Jan 19, 2024 | Common Stock | MOption exerciseDisposed | −3,125 | $0.00 | $0 | 146,875 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.